GILD
GILD
NASDAQ · Biotechnology

Gilead Sciences Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$151.60
+0.67 (+0.44%)
Analyst Consensus
Strong Buy
37
Analysts
Very High
Coverage
Buy 30 81%
Hold 7 19%
Sell 0 0%
Price Target
Analyst Price Target +139.2% upside
Low Target $213.16
Average Target $362.68
High Target $477.67
Current Price $151.60
Current
$151.60
Target
$362.68
$213.16 $362.68 avg $477.67
Scenario Analysis
Bear Case
$213.16
40.6%
Low target
Base Case
$362.68
+139.2%
Avg target
Bull Case
$477.67
+215.1%
High target
Risk/Reward
5.3x
Highly favorable
Price in Context
52-Week High
$157.29
-3.6% from high
52-Week Low
$108.46
+39.8% from low
50-Day SMA
$131.98
+14.9% vs SMA
200-Day SMA
$118.67
+27.7% vs SMA
RSI (14)
65.1
Neutral
Target vs 52W High
$362.68
+130.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -3.5%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -54.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +139.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -16.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -24.5%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -65.1%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.9%